Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP585279.RAHYlXTBnMhdl-wt2ecN2PuCBmq-316OBOKu90hL82RJo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP585279.RAHYlXTBnMhdl-wt2ecN2PuCBmq-316OBOKu90hL82RJo130_assertion type Assertion NP585279.RAHYlXTBnMhdl-wt2ecN2PuCBmq-316OBOKu90hL82RJo130_head.
- NP585279.RAHYlXTBnMhdl-wt2ecN2PuCBmq-316OBOKu90hL82RJo130_assertion description "[In our study, CAGE mRNA was expressed in 39.4% of HCC patients, 73.3% of patients with gastric cancer and 30.8% of patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585279.RAHYlXTBnMhdl-wt2ecN2PuCBmq-316OBOKu90hL82RJo130_provenance.
- NP585279.RAHYlXTBnMhdl-wt2ecN2PuCBmq-316OBOKu90hL82RJo130_assertion evidence source_evidence_literature NP585279.RAHYlXTBnMhdl-wt2ecN2PuCBmq-316OBOKu90hL82RJo130_provenance.
- NP585279.RAHYlXTBnMhdl-wt2ecN2PuCBmq-316OBOKu90hL82RJo130_assertion SIO_000772 15756260 NP585279.RAHYlXTBnMhdl-wt2ecN2PuCBmq-316OBOKu90hL82RJo130_provenance.
- NP585279.RAHYlXTBnMhdl-wt2ecN2PuCBmq-316OBOKu90hL82RJo130_assertion wasDerivedFrom befree-20140225 NP585279.RAHYlXTBnMhdl-wt2ecN2PuCBmq-316OBOKu90hL82RJo130_provenance.
- NP585279.RAHYlXTBnMhdl-wt2ecN2PuCBmq-316OBOKu90hL82RJo130_assertion wasGeneratedBy ECO_0000203 NP585279.RAHYlXTBnMhdl-wt2ecN2PuCBmq-316OBOKu90hL82RJo130_provenance.